In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ami, Diletta ^a   Lavatelli, Francesca ^b   Rognoni, Paola ^b   Palladini, Giovanni ^b   Raimondi, Sara ^b   Giorgetti, Sofia ^b   Monti, Luca ^b   Doglia, Silvia Maria ^a   Natalello, Antonino ^a   Merlini, Giampaolo ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN BINDING;

ABDOMINAL FAT; AL AMYLOIDOSIS; AMYLOID PLAQUE; BETA SHEET; CARDIAC MUSCLE; CHEMISTRY; FEMALE; HUMAN; INFRARED SPECTROSCOPY; MALE; METABOLISM; PATHOLOGY; PROTEINOSIS;

ABDOMINAL FAT; AMYLOIDOGENIC PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS; MALE; MYOCARDIUM; PLAQUE, AMYLOID; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; PROTEIN CONFORMATION, BETA-STRAND; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84977275777     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29096     Document Type: Article

References (70)

1. Merlini, G., & Bellotti, V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349, 583-596 (2003)
2. Chiti, F., & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (2006)
3. Blancas-Mejía, L. M., & Ramirez-Alvarado, M. Systemic amyloidoses. Annu. Rev. Biochem. 82, 745-774 (2013)
4. Sipe, J. D., et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21, 221-224 (2014)
5. Fernandez de Larrea, C., et al A practical approach to the diagnosis of systemic amyloidoses. Blood 125 2239-2244 (2015)
6. Westermark, G. T., Johnson, K. H., & Westermark, P. Staining methods for identification of amyloid in tissue. Methods Enzymol. 309, 3-25 (1999)
7. Merlini, G., Seldin, D. C., & Gertz, M. A. Amyloidosis: Pathogenesis and New Therapeutic Options. J. Clin. Oncol. 29, 1924-1933 (2011)
8. Merlini, G., Comenzo, R. L., Seldin, D. C., Wechalekar, A., & Gertz, M. A. Immunoglobulin light chain amyloidosis. Expert Rev. Hematol. 7, 143-156 (2014)
9. Westermark, P., Davey, E., Lindbom, K., & Enqvist, S. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. Acta Histochem. 108, 209-213 (2006)
10. Stoppini, M., & Bellotti, V. Systemic amyloidosis: Lessons from β 2-microglobulin. J. Biol. Chem. 290, 9951-9958 (2015)
11. Blancas-Mejía, L. M., Hammernik, J., Marin-Argany, M., & Ramirez-Alvarado, M. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans. J. Biol. Chem. 290, 4953-4965 (2015)
12. Rognoni, P., et al. A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in E. coli. PLoS ONE 8(9), e76022, doi: 10.1371/journal.pone.0076022 (2013)
13. Poshusta, T. L., Katoh, N., Gertz, M. A., Dispenzieri, A., & Ramirez-Alvarado, M. Thermal stability threshold for amyloid formation in light chain amyloidosis. Int. J. Mol. Sci. 14, 22604-22617 (2013)
14. Barth, A. Infrared spectroscopy of proteins. Biochim. Biophys. Acta. 1767, 1073-1101 (2007)
15. Sarroukh, R., Goormaghtigh, E., Ruysschaert, J.-M., & Raussens, V. ATR-FTIR: A "rejuvenated" tool to investigate amyloid proteins. Biochim. Biophys. Acta. 1828, 2328-2338 (2013)
16. Casal, H. L., & Mantsch, H. H. Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim. Biophys. Acta. 779, 381-401 (1984)
17. Ami, D., Natalello, A., & Doglia, S. M. In Intrinsically Disordered Protein Analysis: Volume 1, Methods and Experimental Tools Methods in Molecular Biology (eds V. N. Uversky & A. K. Dunker) 85-100 (Humana Press, 2012)
18. Ami, D., et al. Embryonic stem cell differentiation studied by FT-IR spectroscopy. Biochim. Biophys. Acta. 1783, 98-106 (2008)
19. Choo, L. P., et al. In situ characterization of beta-Amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared Microspectroscopy. Biophys J. 71, 1672-1679 (1996)
20. Araki, K., et al. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients. Sci. Rep. 5, 17625, doi: 10.1038/srep17625 (2015)
21. Caine, S., Heraud, P., Tobin, M. J., McNaughton, D., & Bernard, C. C. A. The application of Fourier transform infrared microspectroscopy for the study of diseased central nervous system tissue. NeuroImage 59, 3624-3640 (2012)
22. André, W., Sandt, C., Dumas, P., Djian, P., & Hoffner, G. Structure of inclusions of huntington's disease brain revealed by synchrotron infrared microspectroscopy: Polymorphism and relevance to cytotoxicity. Anal. Chem. 85, 3765-3773 (2013)
23. Kuzyk, A., et al. Association among Amyloid Plaque, Lipid, and Creatine in Hippocampus of TgCRND8 Mouse Model for Alzheimer Disease. J. Biol. Chem. 285, 31202-31207 (2010)
24. Liao, C. R., et al. Synchrotron FTIR reveals lipid around and within amyloid plaques in transgenic mice and alzheimer's disease brain. Analyst 138, 3991-3997 (2013)
25. Zohdi, V., et al. Importance of Tissue Preparation Methods in FTIR Micro-Spectroscopical Analysis of Biological Tissues: ?Traps for New Users?. PLoS ONE 10(2), e0116491, doi: 10.1371/journal.pone.0116491 (2015)
26. Seshadri, S., Khurana, R., & Fink, A. L. Fourier transform infrared spectroscopy in analysis of protein deposits. Methods Enzymol. 309, 559-576 (1999)
27. Zandomeneghi, G., Krebs, M. R. H., McCammon, M. G., & Fandrich, M. FTIR reveals structural differences between native betasheet proteins and amyloid fibrils. Protein Sci. 13, 3314-3321 (2004)
28. Natalello, A., & Doglia, S. M. In Insoluble Proteins Vol. 1258 Methods in Molecular Biology (ed E Garcia-Fruitos) 347-369 (Springer New York, 2015)
29. Arrondo, J. L. R., & Goñi, F. M. Infrared studies of protein-induced perturbation of lipids in lipoproteins and membranes. Chem. Phys. Lipids. 96, 53-68 (1998)
30. Susi, H., & Byler, D. M. Resolution-Enhanced Fourier-Transform Infrared-Spectroscopy of Enzymes. Methods Enzymol. 130, 290-311 (1986)
31. Haris, P. I., Molle, G., & Duclohier, H. Conformational Changes in Alamethicin Associated with Substitution of Its a -Methylalanines with Leucines: A FTIR Spectroscopic Analysis and Correlation with Channel Kinetics. Biophys J. 86, 248-253 (2004)
32. Haris, P. I., & Severcan, F. FTIR spectroscopic characterization of protein structure in aqueous and non-Aqueous media. J Mol Catal B: Enzym 7, 207-221 (1999)
33. Ami, D., Natalello, A., Taylor, G., Tonon, G., & Doglia, S. M. Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. Biochim. Biophys. Acta. 1764, 793-799 (2006)
34. Hazenberg, B. P. C., et al. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid 14, 133-140 (2007)
35. Liu, J., & Conboy, J. C. Structure of a gel phase lipid bilayer prepared by the Langmuir-Blodgett/ Langmuir-Schaefer method characterized by sum-frequency vibrational spectroscopy. Langmuir 21, 9091-9097 (2005)
36. Suhalim, J. L., et al. Characterization of cholesterol crystals in atherosclerotic plaques using stimulated Raman scattering and secondharmonic generation microscopy. Biophys J. 102, 1988-1995 (2012)
37. Tantipolphan, R., Rades, T., Strachan, C. J., Gordon, K. C., & Medlicott, N. J. Analysis of lecithin-cholesterol mixtures using Raman spectroscopy. J. Pharm. Biomed. Anal. 41, 476-484 (2006)
38. Natalello, A., Sasso, F., & Secundo, F. Enzymatic transesterification monitored by an easy-to-use Fourier transform infrared spectroscopy method. Biotechnol. J. 8, 133-138 (2013)
39. Brézillon, S., et al. Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging. Anal. Bioanal. Chem. 406, 5795-5803 (2014)
40. Fukuyama, Y., Yoshida, S., Yanagisawa, S., & Shimizu, M A study on the differences between oral squamous cell carcinomas and normal oral mucosas measured by Fourier transform infrared spectroscopy. Biospectroscopy 117-126 5(1999)
41. Gough, K. M., Zelinski, D., Wiens, R., Rak, M., & Dixon, I. M. C. Fourier transform infrared evaluation of microscopic scarring in the cardiomyopathic heart: Effect of chronic AT1 suppression. Anal. Biochem. 316, 232-242 (2003)
42. Arsov, Z., & Quaroni, L. Detection of lipid phase coexistence and lipid interactions in sphingomyelin/cholesterol membranes by ATR-FTIR spectroscopy. Biochim. Biophys. Acta. 1778, 880-889 (2008)
43. Levchuk, Y. N. Infrared Spectra of Steroids. Russ. Chem. Rev. 37, 155-171 (1968)
44. Linke, R. P., Gartner, H. V., & Michels, H. High-sensitivity diagnosis of AA amyloidosis using congo red and immunohistochemistry detects missed amyloid deposits. J. Histochem. Cytochem. 43, 863-869 (1995)
45. van Gameren, II, Hazenberg, B. P. C., Bijzet, J., & van Rijswijk, M. H. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum-Us 54, 2015-2021 (2006)
46. Baker, M. J., et al. Using Fourier transform IR spectroscopy to analyze biological materials. Nat. Protoc. 9, 1771-1791 (2014)
47. Petibois, C., & Desbat, B. Clinical application of FTIR imaging: new reasons for hope. Trends Biotechnol. 28, 495-500 (2010)
48. Gertz M., et al. Cardiac and renal biomarker responses in a phase 1/2 study of NEOD001 in patients with AL amyloidosis and persistent organ dysfunction. Journal of Clinical Oncology 33 (2015)
49. Langer, A., et al. Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis. Blood 126, 188 (2015)
50. Richards, D. B., et al. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. N Engl J Med 373, 1106-1114 (2015)
51. Pepys, M. B., et al. Human serum amyloid-p component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91, 5602-5606 (1994)
52. Sethi, S., et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney International 82, 226-234 (2012)
53. Bellotti, V., & Chiti, F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr. Opin. Struct. Biol. 18, 771-779 (2008)
54. Relini, A., et al. Collagen plays an active role in the aggregation of β 2- microglobulin under physiopathological conditions of dialysisrelated amyloidosis. J. Biol. Chem. 281, 16521-16529 (2006)
55. Relini, A., et al. Heparin strongly enhances the formation of β 2-microglobulin amyloid fibrils in the presence of type I collagen. J. Biol. Chem. 283, 4912-4920 (2008)
56. Harris, D. L., King, E., Ramsland, P. A., & Edmundson, A. B. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes. J. Mol. Recognit. 13, 198-212 (2000)
57. Ren, R., et al. Role of Glycosaminoglycan Sulfation in the Formation of Immunoglobulin Light Chain Amyloid Oligomers and Fibrils. J. Biol. Chem. 285, 37672-37682 (2010)
58. Brambilla, F., et al. Shotgun Protein Profile of Human Adipose Tissue and Its Changes in Relation to Systemic Amyloidoses. J. Proteome Res. 12, 5642-5655 (2013)
59. Sun, X., et al. Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis. Amyloid 13, 20-23 (2006)
60. Burns, M. P., et al. Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques. Mol. Brain. Res. 110, 119-125 (2003)
61. Solé-Domènech, S., et al. Localization of cholesterol, amyloid and glia in Alzheimer's disease transgenic mouse brain tissue using time-of-flight secondary ion mass spectrometry (ToF-SIMS) and immunofluorescence imaging. Acta Neuropathol. 125, 145-157 (2013)
62. Singh, S., Trikha, S., Bhowmick, D., Sarkar, A., & Jeremic, A. In Lipids in Protein Misfolding Vol. 855 Advances in Experimental Medicine and Biology (ed Olga Gursky) Ch. 4, 95-116 (Springer International Publishing, 2015)
63. Morgado, I., & Garvey, M. In Lipids in Protein Misfolding Vol. 855 Advances in Experimental Medicine and Biology (ed Olga Gursky) Ch. 3, 67-94 (Springer International Publishing, 2015)
64. Ryan, T., Mok, Y.-F., Howlett, G., & Griffin, M. W. In Lipids in Protein Misfolding Vol. 855 Advances in Experimental Medicine and Biology (ed Olga Gursky) Ch. 7, 157-174 (Springer International Publishing, 2015)
65. Reed, B., et al. Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis. JAMA Neurol. 71, 195-200 (2014)
66. Refolo, L. M., et al. A cholesterol-lowering drug reduces beta-Amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8, 890-899 (2001)
67. Bellotti, V., Mangione, P., & Merlini, G. Review: Immunoglobulin light chain amyloidosis-The archetype of structural and pathogenic variability. J. Struct. Biol. 130, 280-289 (2000)
68. Jackson M., Haris, P. I., & Chapman, D. Fourier transform infrared spectroscopic studies of calcium-binding proteins. Biochemistry30, 9681-9686 (1991)
69. Stoppini, M., et al. Proteomics of beta 2-microglobulin amyloid fibrils. Biochim. Biophys. Acta. 1753, 23-33 (2005)
70. Klunk, W. E., Pettegrew, J. W., & Abraham, D. J. Quantitative-evaluation of congo red binding to amyloid-like proteins with a betapleated sheet conformation. J. Histochem. Cytochem. 37, 1273-1281 (1989)